ICARES Medicus Inc(TW:6612)
NT$68.50-0.90 (-1.30%)
TW:6612
ICARES Medicus Inc financials statements
NT$68.50
At close:-0.90 (-1.30%)
ICARES Medicus Inc (6612) Ratios
ICARES Medicus Inc Ratios
TW:6612's free cash flow for Q2 2026 was NT$43.14M. For the 2026 fiscal year, TW:6612's free cash flow was decreased by NT$-8.40M and operating cash flow was NT$51.53M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.04 | 2.46 | 10.45 | 7.11 | 4.81 |
| Quick Ratio | 1.53 | 1.87 | 9.40 | 6.25 | 4.30 |
| Cash Ratio | 0.55 | 0.77 | 3.08 | 3.06 | 3.07 |
| Solvency Ratio | 0.13 | 0.15 | 0.59 | 1.49 | 0.60 |
| Operating Cash Flow Ratio | -0.07 | -0.02 | -0.21 | 1.39 | 0.33 |
| Short-Term Operating Cash Flow Coverage | -0.10 | -0.03 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 489.66M | NT$ 167.92M | NT$ 1.05B | NT$ 555.30M | NT$ 411.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.30 | 0.06 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.48 | 0.54 | 0.08 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.32 | 0.35 | 0.07 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.16 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.73 | 1.81 | 1.21 | 1.19 | 1.29 |
| Debt Service Coverage Ratio | 0.34 | 0.40 | 16.08 | 246.02 | 84.50 |
| Interest Coverage Ratio | 5.32 | 6.72 | 16.54 | 220.73 | 109.79 |
| Debt to Market Cap | 0.23 | 0.13 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 19.10 | 17.66 | 3.06 | 0.16 | 0.44 |
| Net Debt to EBITDA | 1.49 | 1.69 | -1.58 | -1.60 | -3.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.08% | 69.75% | 79.68% | 81.56% | 81.97% |
| EBIT Margin | 11.37% | 20.98% | 19.90% | 28.07% | 19.34% |
| EBITDA Margin | 24.61% | 31.33% | 27.12% | 34.08% | 26.88% |
| Operating Profit Margin | 11.37% | 14.34% | 19.60% | 24.84% | 23.10% |
| Pretax Profit Margin | 5.99% | 19.12% | 18.71% | 27.96% | 18.58% |
| Net Profit Margin | 0.27% | 11.99% | 16.14% | 25.19% | 14.88% |
| Continuous Operations Profit Margin | 0.27% | 6.34% | 10.64% | 22.38% | 10.04% |
| Net Income Per EBT | 4.53% | 62.73% | 86.26% | 90.08% | 80.07% |
| EBT Per EBIT | 52.67% | 133.39% | 95.49% | 112.56% | 80.42% |
| Return on Assets (ROA) | 0.10% | 3.43% | 5.12% | 12.35% | 6.07% |
| Return on Equity (ROE) | 0.17% | 6.21% | 6.19% | 14.67% | 7.85% |
| Return on Capital Employed (ROCE) | 5.48% | 5.06% | 6.65% | 13.38% | 10.71% |
| Return on Invested Capital (ROIC) | 0.19% | 1.43% | 3.74% | 10.25% | 5.41% |
| Return on Tangible Assets | 0.13% | 4.91% | 5.46% | 13.89% | 7.27% |
| Earnings Yield | 0.10% | 1.95% | 2.45% | 5.16% | 2.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.02 | 3.36 | 3.92 | 3.87 | 4.38 |
| Payables Turnover | 13.78 | 10.84 | 21.46 | 16.10 | 18.62 |
| Inventory Turnover | 1.09 | 0.76 | 0.95 | 1.52 | 1.21 |
| Fixed Asset Turnover | 2.15 | 1.80 | 2.55 | 5.09 | 3.69 |
| Asset Turnover | 0.36 | 0.29 | 0.32 | 0.49 | 0.41 |
| Working Capital Turnover Ratio | 1.32 | 0.86 | 0.70 | 1.01 | 0.98 |
| Cash Conversion Cycle | 428.49 | 553.73 | 460.81 | 312.00 | 364.83 |
| Days of Sales Outstanding | 120.87 | 108.71 | 93.14 | 94.42 | 83.28 |
| Days of Inventory Outstanding | 334.11 | 478.70 | 384.68 | 240.25 | 301.15 |
| Days of Payables Outstanding | 26.49 | 33.67 | 17.01 | 22.67 | 19.61 |
| Operating Cycle | 454.98 | 587.41 | 477.82 | 334.67 | 384.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.25 | -0.21 | -0.61 | 3.11 | 0.93 |
| Free Cash Flow Per Share | -2.31 | -3.24 | -2.43 | 2.29 | 0.78 |
| Dividend Paid and CapEx Coverage Ratio | -0.94 | -0.07 | -0.23 | 2.53 | 3.91 |
| Capital Expenditure Coverage Ratio | -1.19 | -0.07 | -0.34 | 3.79 | 5.96 |
| Operating Cash Flow Coverage Ratio | -0.07 | -0.01 | -0.21 | 20.93 | 2.20 |
| Operating Cash Flow to Sales Ratio | -0.05 | -0.01 | -0.04 | 0.25 | 0.10 |
| Free Cash Flow Yield | -3.44% | -3.16% | -2.57% | 3.80% | 1.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 61.59 | 51.46 | 40.78 | 19.35 | 35.92 |
| Price-to-Sales (P/S) Ratio | 2.79 | 6.16 | 6.58 | 4.88 | 5.34 |
| Price-to-Book (P/B) Ratio | 1.72 | 3.19 | 2.53 | 2.84 | 2.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.11 | -31.60 | -38.97 | 26.32 | 65.58 |
| Price-to-Operating Cash Flow Ratio | -53.60 | -489.15 | -154.54 | 19.37 | 54.57 |
| Price-to-Earnings Growth (PEG) Ratio | -1.36 | -3.62 | -1.61 | 0.16 | 2.83 |
| Enterprise Value Multiple | 12.82 | 21.34 | 22.69 | 12.72 | 16.68 |
| Enterprise Value | 3.57B | 5.75B | 3.73B | 2.22B | 1.77B |
| EV to EBITDA | 12.82 | 21.34 | 22.69 | 12.72 | 16.68 |
| EV to Sales | 3.15 | 6.69 | 6.15 | 4.34 | 4.48 |
| EV to Free Cash Flow | -32.93 | -34.32 | -36.43 | 23.39 | 55.03 |
| EV to Operating Cash Flow | -60.64 | -531.20 | -144.48 | 17.21 | 45.79 |
| Tangible Book Value Per Share | 24.19 | 16.56 | 36.83 | 19.82 | 17.71 |
| Shareholders’ Equity Per Share | 39.06 | 32.11 | 37.46 | 21.18 | 18.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.95 | 0.67 | 0.43 | 0.23 | 0.49 |
| Revenue Per Share | 24.08 | 16.63 | 14.37 | 12.34 | 9.55 |
| Net Income Per Share | 0.07 | 1.99 | 2.32 | 3.11 | 1.42 |
| Tax Burden | 0.05 | 0.63 | 0.86 | 0.90 | 0.80 |
| Interest Burden | 0.53 | 0.91 | 0.94 | 1.00 | 0.96 |
| Research & Development to Revenue | 0.14 | 0.22 | 0.29 | 0.26 | 0.27 |
| SG&A to Revenue | 0.27 | 0.32 | 0.31 | 0.31 | 0.32 |
| Stock-Based Compensation to Revenue | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
| Income Quality | -19.16 | -0.07 | -0.26 | 0.90 | 0.53 |
Currency in TWD
